CID 101944494

Irbesartan metabolite 5

Structural Information

Molecular Formula
C25H28N6O2
SMILES
CCCCC1=NC2(CCC(C2)O)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5
InChI
InChI=1S/C25H28N6O2/c1-2-3-8-22-26-25(14-13-19(32)15-25)24(33)31(22)16-17-9-11-18(12-10-17)20-6-4-5-7-21(20)23-27-29-30-28-23/h4-7,9-12,19,32H,2-3,8,13-16H2,1H3,(H,27,28,29,30)
InChIKey
SGLAKMDXJPVHBY-UHFFFAOYSA-N
Compound name
2-butyl-8-hydroxy-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-1,3-diazaspiro[4.4]non-1-en-4-one
Related CIDs

2D Structure

compound 2d structure
2
Annotation Hits

0
References

0
Patents

444.2274 Da
Monoisotopic Mass

3.2
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 445.23468 205.4
[M+Na]+ 467.21662 212.4
[M-H]- 443.22012 211.8
[M+NH4]+ 462.26122 212.2
[M+K]+ 483.19056 204.5
[M+H-H2O]+ 427.22466 193.1
[M+HCOO]- 489.22560 217.8
[M+CH3COO]- 503.24125 212.1
[M+Na-2H]- 465.20207 199.3
[M]+ 444.22685 203.6
[M]- 444.22795 203.6
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

No patent data available for this compound.